Navigation Links
Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Celebrates 25 Years of Improving Patient Care
Date:4/2/2009

nued McMorrow "for the commitment they personally bring to their jobs, in helping improve health care by the work they do."

Verathon is best known for its BladderScan brand, a line of bladder volume measurement instruments that has fueled the growth of the company from a small start-up to a profitable international corporation. Noninvasive and easy to use, BladderScan(R) is clinically proven to prevent unnecessary urinary catheterizations and reduce rates of urinary tract infection. This is of significant importance to hospitals, in light of changing Medicare reimbursement for catheter-related UTIs, beginning in October, 2008. BladderScan also helps diagnose urinary-related problems such as enlarged prostate (BPH) and bladder outlet obstruction (BOO), of importance to the growing number of Baby Boomers and the health care providers who treat them. Now a standard of care for noninvasive bladder volume measurement, the BladderScan is used in Urology, Acute Care, Primary Care and Extended Care.

The company expanded its product portfolio in January 2006 with the acquisition of Saturn Biomedical Systems and the GlideScope Video Laryngoscope (GVL) brand. GlideScope(R) devices provide a consistently clear view of the airway, enabling quick intubation, and offer significant benefits to Anesthesiology, Critical Care, Emergency, EMS and Military health care providers. The brand was recently featured in a segment of NBC's "ER - The Final Season." The GlideScope Ranger is currently being used by the military in both Afghanistan and Iraq.

For more information, please visit www.verathon.com.

Media Contact: Jane Mueller, VP of Marketing, Verathon Medical Inc., 425.867.1348, Ext. 5600.

Alternate Contacts: Nansea Carmichael, Executive Assistant -Marketing; 425.867.1348, Ext. 5607.

Copyright(C) 2009, Verathon Inc. Bl
'/>"/>

SOURCE Verathon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
2. GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army
3. Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine
4. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
5. Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode
6. Aircraft Medical Files Counter Action Against Verathon
7. Verathon Inc., maker of GlideScope(R) Video Laryngoscopes, Introduces Free Grant Writing Kit for EMS Professionals
8. European Patent Office Upholds Verathons IP Against Aircraft Medical Challenge
9. Verathon Inc., Maker of BladderScan(R) and GlideScope(R), Ranks in Deloittes 2007 Washington State Technology Fast 50 for 4th Time in Past 6 Years
10. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
11. Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)....,Nov.25/PRNewswire-USNewswire/--AnarticlebyJanetW...tionandResearch,titled"ADifficultBalance-PainManag...9issueofTheNewEnglandJournalofMedicine. ,, (Log...ALOGO ) ,, Inthearticle,WoodcockdiscussesFDAeff...orthosewhoneeditandmanagingtherisksposedbyvariousa...
(Date:11/25/2009)...Endorsements,Business,andPressJoinEfforttoEducate ...--Onceagain,theNationalBipolarFoundationandtheMedi..."Safe,tilStable"program,whichisnowbeingwidelyaccep...r.Today,theNationalBipolarFoundationreceivedaprocl...romtheLt.GovernorofLouisianaMitchLandrieu.TheNatio...
(Date:11/25/2009)...ery that grew out of a collaboration between UCLA ...ope to the nearly 10 million Americans who suffer ...wn as hardening of the arteries, peripheral arteri...m in which narrowed arteries reduce blood flow to ...for vascular disease, heart attack and stroke, and...
(Date:11/25/2009)... to fight rheumatoid arthritis, could help newly d...ESDAY, Nov. 25 (HealthDay News) -- A drug commonly...id arthritis now also shows some promise in helpin..., The drug, rituximab (Rituxan), helped patients...ough the disease had destroyed some of their pancr...
(Date:11/25/2009)... by neurological symptoms, study finds , ...gical side effects are among the potential problem...r who were treated with cisplatin-based chemothera... 1,409 Norwegian men treated for unilateral testic... a follow-up survey conducted from 1998 to 2002. ,...
Breaking Medicine News(10 mins):Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
...udy, marijuana enhances the efficacy of drug treat... affected by this fatal viral infection. The findi...offer medical benefits in certain situations. ...eme fatigue, nausea, muscle aches, loss of appetit...
... cancer from Canada states that young women betwee...e of cancer than young men. // The national r... the Public Health Agency of Canada on people aged...ries, with projections to 2005. Dr. Loraine...
...half of hundreds of HIV-positive Libyan children h...on dinars ($11.6 million) in compensation. // ...sday, which was retrying six foreign medics who ha... a Palestinian doctor that had begun in May that t...
...loped that would reduce the bio-terrorism threat o... Biomedical researchers at the University of Tex...ed to start the initial step in the development of... the specific structure of a protein that the viru...
...dren are not checked properly for their safety and...ical Center researchers. // The drugs that are bei...ants, antiseizure medications and sedatives. ...istration (FDA) may extend the period of time that...
...mber of HIV infected individuals, India plans to a...e in the country to // teach others about safe sex...could be weavers, or agricultural laborers or just...istribution of condoms, and messages on radio and ...
Other Medicine News:Health News:Cancer Rates Falls In Younger Men But Stable In Young Women 2Health News:Libyan Lawyers For The HIV-positive Children Seek 15million Dinars As Compensation 2Health News:A New drug Developed To Fight The Bio-Terrorism Threat Of VEE Virus 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 2Health News:Doctors Unaware If Pediatric Dosages Are Safe 3
(Date:11/24/2009)..., FREMONT,Calif.,Nov.24/PRNewswire-FirstCall/--Ver...mpanyfileditsPlanofReorganizationandDisclosureStat...ruptcyCourtfortheDistrictofDelaware.Ahearingtocons...eduledforDecember8,2009,withthehearingontheconfirm...PlancallsfortheCompanytopayallclaimsinfull.ThePlan...
(Date:11/24/2009)..., WOODCLIFFLAKE,N.J.andNEWYORK,Nov.24/PRNewswire/-...oodandDrugAdministration(FDA)hasacceptedforreviewE...pt®(donepezilHClextendedrelease)tabletsforthe...Thisnewhigherdoseformulationcontains23mgofdonepezi...verysystemthatallowsforgradualreleaseofthedrug.The...
(Date:11/24/2009)..., PLEASANTON,Calif.,Nov.24/PRNewswire-FirstCall/--...evice-basedmechanicalcirculatorysupporttherapiesto...twillbeparticipatinginthe21stAnnualPiperJaffrayHea....Smith,executivevicepresidentandchieffinancialoffi...0a.m.,EasternStandardTime(5:30a.m.,PacificStandard...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Living in U S May Raise Hispanics Cancer Risk 53835 1Living in U S May Raise Hispanics Cancer Risk 53835 2Living in U S May Raise Hispanics Cancer Risk 53835 3Oncothyreon announces webcast of second quarter 2009 financial results conference call 13414 1China Sky One Medical Inc Appoints New Independent Director 13412 1China Sky One Medical Inc Appoints New Independent Director 13412 2China Sky One Medical Inc Appoints New Independent Director 13412 3
...Lilly and Company,(NYSE: LLY ), strongly disagree...s alleged by the Connecticut Attorney General Rich...2008., The tone and content of the release is a d...Zyprexa to treat a life-threatening disease.,Speci...ment of the,seriousness of schizophrenia or bipola...
...h 12 Genta,Incorporated (Nasdaq: GNTA ) today an...rter and year ended December 31, 2007. The Company... -- AGENDA Phase 3 trial using key biomarker i... completes initial Phase 1 trial; planned 505...ane, becomes new clinical-stage product -- Genas...
Other Medicine Technology:Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 2Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 3Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10
Nagashima Rigid Fiber Optic Antroscope SFA-II-W
Kaye Skin Hook
Joseph Single Hook
Cottle Single Hook
Medicine Products: